Skip to content

Neutralizing Antibody Level After COVID-19 Vaccination

Neutralizing Antibody Level After COVID-19 Vaccination in Hospital Works.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05083026
Enrollment
51
Registered
2021-10-19
Start date
2021-06-02
Completion date
2024-12-31
Last updated
2023-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Brief summary

1. serial of neutralizing antibody at 2, 4, 6, 9, 12 month after COVID-19 vaccination 2. investigate the factors on antibody titer.

Detailed description

1. serial of neutralizing antibody at 2, 4, 6, 9, 12 month after COVID-19 vaccination 1) semi-quantitative measurement of neutralizing antibody at 2, 4, 6, 9, 12 month after COVID-19 vaccination 2) investigate the duration maintaining acceptable range (over 30% inhibition) 2. investigate the factors on antibody titer at 2 month after vaccination 1) potential factors: age, sex, body weight, height, use of medication, use of antipyretics (NSAID or tyrenol), side effect of COVID-19 vaccination 2) correlation between antibody titer and potential factors 3. Compare 4 diagnostic ELISA kit at 2 month after vaccination 1) measure neutralizung antibody using ELISA kits from 4 different companies 2) investigate correlation coefficient of antibody titer between companies

Interventions

DIAGNOSTIC_TESTCOVID-19 neutralizing antibody

This study enrolled persons already who received COVID-19 vaccination under government policy. 1. We collect 5mL blood at 2, 4, 6, 9, 12 months after COVID-19 vaccination 2. isolate serum and store in -80 degree deep freezer 3. measure neutralizing Antibody

Sponsors

Kyungpook National University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years

Inclusion criteria

* healthcare works after completion of COVID-19 vaccination * 20-60 years * sign the agreement of study

Exclusion criteria

* serious underlying diseases

Design outcomes

Primary

MeasureTime frameDescription
titer of neutralizing antibody after COVID-19 vaccinationat 2month after COVID-19 vaccinationsemi-quantitative measurement of neutralizing antibody after COVID-19 vaccination
body weight (Kg)at 2 month after COVID-19 vaccinationcorrelation between antibody titer and body weight: spearmann's correlation
body mass index (kg/m^2)at 2 month after COVID-19 vaccinationcorrelation between antibody titer and body weight: spearmann's correlation
Compare 4 diagnostic ELISA kit after COVID-19 vaccinationat 2 month after COVID-19 vaccination1. measure neutralizung antibody using ELISA kits from 4 different companies 2 months after COVID-19 vaccination 2. investigate correlation coefficient of antibody titer between companies

Countries

South Korea

Contacts

Primary ContactSu Youn Nam, MD, PhD
nam20131114@gmail.com82-53-200-2610

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026